CML

(redirected from chronic myelocytic leukemia)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to chronic myelocytic leukemia: myelogenous, chronic granulocytic leukemia

CML

See: Capital market line

Capital Market Line

In the capital asset pricing model, a line that plots the extra return an investor expects for each change in the level of risk. Rational investors expect higher returns for riskier assets and the capital market line shows this graphically. A portfolio that accurately reflects the capital market line is considered a Markowitz efficient portfolio. The slope of the capital market line is a calculation of the equilibrium market price of risk. See also: Beta.
Mentioned in ?
References in periodicals archive ?
* The report provides a snapshot of the global therapeutic landscape of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H2 2015
A three way complex translocation (4;9;22) in two patients with chronic myelocytic leukemia. J Cancer Res Ther 2005;1:108-10 (BRIEF COMMUNICATIONS),
Variant Philadelphia translocations with different breakpoints in six chronic myeloid leukemia patients / Alti kronik miyeloid losemi olgusunda farkli kirik noktali varyant Philadelphia translokasyonlari
Translocation of c-abl oncogene correlates with the presence of Philadelphia chromosome in chronic myelocytic leukemia. Nature.
Pioneering advances in molecular hematology
CHRONIC MYELOGENOUS LEUKEMIA (CML) - also known as Chronic Granulocytic Leukemia (CGL), Chronic Myelocytic Leukemia, Chronic Myelosis or Chronic Myeloid Leukemia - is one of the four main type of leukemia, accounting for 20 percent to 25 percent of all leukemia cases.
Chronic myelogenous leukemia
Global Markets Direct's, 'Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016', provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) pipeline landscape.
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016
Treatment of chronic myelocytic leukemia (CML) with imatinib is encouraging and it has an acceptable toxicity profile, and as such has changed the management of CML during the last decade.
Non-Hodgkin's lymphoma in a chronic myelocytic leukemia patient treated with imatinib / Imatinib alan bir kronik miyeloid losemi olgusunda gelisen non-Hodgkin lenfoma

Financial browser ?
Full browser ?